Literature DB >> 22002429

Gene knockout of tau expression does not contribute to the pathogenesis of prion disease.

Victoria A Lawson1, Helen M Klemm, Jeremy M Welton, Colin L Masters, Peter Crouch, Roberto Cappai, Giuseppe D Ciccotosto.   

Abstract

Prion diseases or transmissible spongiform encephalopathies are a group of fatal and transmissible disorders affecting the central nervous system of humans and animals. The principal agent of prion disease transmission and pathogenesis is proposed to be an abnormal protease-resistant isoform of the normal cellular prion protein. The microtubule-associated protein tau is elevated in patients with Creutzfeldt-Jakob disease. To determine whether tau expression contributes to prion disease pathogenesis, tau knockout and control wild-type mice were infected with the M1000 strain of mouse-adapted human prions. Immunohistochemical analysis for total tau expression in prion-infected wild-type mice indicated tau aggregation in the cytoplasm of a subpopulation of neurons in regions associated with spongiform change. Western immunoblot analysis of brain homogenates revealed a decrease in total tau immunoreactivity and epitope-specific changes in tau phosphorylation. No significant difference in incubation period or other disease features were observed between tau knockout and wild-type mice with clinical prion disease. These results demonstrate that, in this model of prion disease, tau does not contribute to the pathogenesis of prion disease and that changes in the tau protein profile observed in mice with clinical prion disease occurs as a consequence of the prion-induced pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22002429     DOI: 10.1097/NEN.0b013e318235b471

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  5 in total

Review 1.  Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders.

Authors:  Xuling Li; Simon James; Peng Lei
Journal:  J Mol Neurosci       Date:  2016-09-15       Impact factor: 3.444

2.  Phosphorylated human tau associates with mouse prion protein amyloid in scrapie-infected mice but does not increase progression of clinical disease.

Authors:  Brent Race; Katie Phillips; Allison Kraus; Bruce Chesebro
Journal:  Prion       Date:  2016-07-03       Impact factor: 3.931

Review 3.  Is tau ready for admission to the prion club?

Authors:  Garth F Hall; Brian A Patuto
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

4.  iPS Cell Cultures from a Gerstmann-Sträussler-Scheinker Patient with the Y218N PRNP Mutation Recapitulate tau Pathology.

Authors:  Andreu Matamoros-Angles; Lucía Mayela Gayosso; Yvonne Richaud-Patin; Angelique di Domenico; Cristina Vergara; Arnau Hervera; Amaya Sousa; Natalia Fernández-Borges; Antonella Consiglio; Rosalina Gavín; Rakel López de Maturana; Isidro Ferrer; Adolfo López de Munain; Ángel Raya; Joaquín Castilla; Rosario Sánchez-Pernaute; José Antonio Del Río
Journal:  Mol Neurobiol       Date:  2017-05-02       Impact factor: 5.590

Review 5.  Genetics of prion diseases.

Authors:  Sarah E Lloyd; Simon Mead; John Collinge
Journal:  Curr Opin Genet Dev       Date:  2013-03-19       Impact factor: 5.578

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.